|Quest Diagnostics Reports Third Quarter 2017 Financial Results, Updates 2017 Financial Guidance and Reaffirms Long Term Outlook|
|- Third quarter revenues of $1.93 billion, up 2.4% versus 2016.
- Third quarter reported diluted EPS of $1.15, down 14.2% from 2016, which included an acquisition escrow recovery gain; and $1.39 on an adjusted basis excluding amortization, up 1.5% from 2016. Excess tax benefit associated with stock-based compensation benefited diluted EPS by $0.04 in the quarter and increased $0.02 compared to 2016.
- Updates outlook for full year 2017 primarily due to the financial impact of hurricanes an... ||10/19/17|
|Quest Diagnostics to Acquire Cleveland HeartLab and Form Strategic Collaboration with Cleveland Clinic|
|- Cleveland HeartLab to be the base for Quest's first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease
- Relationship to establish a strategic collaboration to identify and offer diagnostic services from Cleveland Clinic's innovations in inflammation and other areas of medicine
SECAUCUS, N.J. and CLEVELAND, Oct. 18, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today... ||10/18/17|
|Quest Diagnostics Completes Acquisition of the Outreach Laboratory Services of Two Hartford HealthCare Hospitals in Connecticut|
|Quest acquires service businesses of William W. Backus Hospital and The Hospital of Central Connecticut
SECAUCUS, N.J. and HARTFORD, Conn., Sept. 29, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired the outreach lab services operations of two hospitals of Hartford HealthCare (HHC), The William W. Backus Hospital and The Hospital of Central Connecticut. HHC is an integrated health care system wi... ||09/29/17|
|Quest Diagnostics to Acquire Shiel Medical Laboratory from Fresenius Medical Care|
|Transaction to expand access to Quest's diagnostic innovations in the New York-New Jersey metropolitan area
SECAUCUS, N.J., Sept. 28, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will acquire the Shiel Medical Laboratory business from Fresenius Medical Care, the premier healthcare company focused on delivering the highest quality care to people with renal and other ... ||09/28/17|